A dose finding followed by a phase II study of oral UFT (uracil/tegafur) and lv (leucovorin) plus i.v. mitomycin (MMC) in patients (pts) with metastatic colorectal cancer (MCRC): Phase I results
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3709-3709
E. Maiello
◽
M. Lopez
◽
R. V. Iaffaioli
◽
R. Tambaro
◽
G. Paoletti
◽
...